miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma - PubMed (original) (raw)
. 2013 Oct;34(10):2231-9.
doi: 10.1093/carcin/bgt184. Epub 2013 May 28.
Affiliations
- PMID: 23715501
- DOI: 10.1093/carcin/bgt184
miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma
H W Z Khella et al. Carcinogenesis. 2013 Oct.
Abstract
MicroRNAs (miRNAs) play a crucial role in tumor progression and metastasis. We, and others, recently identified a number of miRNAs that are dysregulated in metastatic renal cell carcinoma compared with primary renal cell carcinoma. Here, we investigated three miRNAs that are significantly downregulated in metastatic tumors: miR-192, miR-194 and miR-215. Gain-of-function analyses showed that restoration of their expression decreases cell migration and invasion in renal cell carcinoma cell line models, whereas knockdown of these miRNAs resulted in enhancing cellular migration and invasion abilities. We identified three targets of these miRNAs with potential role in tumor aggressiveness: murine double minute 2, thymidylate synthase, and Smad Interacting protein 1/zinc finger E-box binding homeobox 2. We observed a convergent effect (the same molecule can be targeted by all three miRNAs) and a divergent effect (the same miRNA can control multiple targets) for these miRNAs. We experimentally validated these miRNA-target interactions using three independent approaches. First, we observed that miRNA overexpression significantly reduces the mRNA and protein levels of their targets. In the second, we observed significant reduction of the luciferase signal of a vector containing the 3'UTR of the target upon miRNA overexpression. Finally, we show the presence of inverse correlation between miRNA changes and the expression levels of their targets in patient specimens. We also examined the prognostic significance of miR-215 in renal cell carcinoma. Lower expression of miR-215 is associated with significantly reduced disease-free survival time. These findings were validated on an independent data set from The Cancer Genome Atlas. These results can pave the way to the clinical use of miRNAs as prognostic markers and therapeutic targets.
Similar articles
- miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.
White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, Evans AJ, Gabril M, Yousef GM. White NM, et al. Br J Cancer. 2011 Nov 22;105(11):1741-9. doi: 10.1038/bjc.2011.401. Epub 2011 Oct 27. Br J Cancer. 2011. PMID: 22033272 Free PMC article. - microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
Wang X, Chen X, Wang R, Xiao P, Xu Z, Chen L, Hang W, Ruan A, Yang H, Zhang X. Wang X, et al. Oncol Rep. 2013 Aug;30(2):643-50. doi: 10.3892/or.2013.2530. Epub 2013 Jun 7. Oncol Rep. 2013. PMID: 23754305 - Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
Liep J, Kilic E, Meyer HA, Busch J, Jung K, Rabien A. Liep J, et al. PLoS One. 2016 Jun 23;11(6):e0157801. doi: 10.1371/journal.pone.0157801. eCollection 2016. PLoS One. 2016. PMID: 27336447 Free PMC article. - MicroRNAs and their target gene networks in renal cell carcinoma.
Redova M, Svoboda M, Slaby O. Redova M, et al. Biochem Biophys Res Commun. 2011 Feb 11;405(2):153-6. doi: 10.1016/j.bbrc.2011.01.019. Epub 2011 Jan 11. Biochem Biophys Res Commun. 2011. PMID: 21232526 Review. - MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
Gu L, Li H, Chen L, Ma X, Gao Y, Li X, Zhang Y, Fan Y, Zhang X. Gu L, et al. Oncotarget. 2015 Oct 20;6(32):32545-60. doi: 10.18632/oncotarget.5324. Oncotarget. 2015. PMID: 26416448 Free PMC article. Review.
Cited by
- wMKL: multi-omics data integration enables novel cancer subtype identification via weight-boosted multi-kernel learning.
Cao H, Jia C, Li Z, Yang H, Fang R, Zhang Y, Cui Y. Cao H, et al. Br J Cancer. 2024 Apr;130(6):1001-1012. doi: 10.1038/s41416-024-02587-w. Epub 2024 Jan 26. Br J Cancer. 2024. PMID: 38278975 - The Role of microRNAs in Gene Expression and Signaling Response of Tumor Cells to an Acidic Environment.
Riemann A, Rauschner M, Reime S, Thews O. Riemann A, et al. Int J Mol Sci. 2023 Nov 29;24(23):16919. doi: 10.3390/ijms242316919. Int J Mol Sci. 2023. PMID: 38069241 Free PMC article. - Identification of hub genes and microRNAs with prognostic values in esophageal cancer by integrated analysis.
Mokhlesi A, Sharifi Z, Berimipour A, Taleahmad S, Talkhabi M. Mokhlesi A, et al. Noncoding RNA Res. 2023 Jun 4;8(3):459-470. doi: 10.1016/j.ncrna.2023.05.009. eCollection 2023 Sep. Noncoding RNA Res. 2023. PMID: 37416747 Free PMC article. - Improving the prediction for the response to radiotherapy of clinical tumor samples by using combinatorial model of MicroRNA expression.
Tang C, Qi J, Wu Y, Luo L, Wang Y, Wu Y, Shi X. Tang C, et al. Front Genet. 2022 Nov 22;13:1069112. doi: 10.3389/fgene.2022.1069112. eCollection 2022. Front Genet. 2022. PMID: 36482894 Free PMC article. - Survival-based bioinformatics analysis to identify hub long non-coding RNAs along with lncRNA-miRNA-mRNA network for potential diagnosis/prognosis of thyroid cancer.
Morovat P, Morovat S, Hosseinpour M, Moslabeh FGZ, Kamali MJ, Samadani AA. Morovat P, et al. J Cell Commun Signal. 2023 Sep;17(3):639-655. doi: 10.1007/s12079-022-00697-9. Epub 2022 Sep 23. J Cell Commun Signal. 2023. PMID: 36149574 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials